STAT News
US · 40 mins ago
STAT+: Pharmalittle: We’re reading about a Novartis acquisition, Republicans backing clinical trial diversity, and more
Novartis is pushing deeper into antibody-drug conjugate development, paying $1.1 billion upfront to buy Myricx Bio
Do you trust STAT News?
Sign in to rate
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!